LIBMELDY - AN OVERVIEW

The pill formulation of zanubrutinib (Brukinsa; BeOne) is currently authorised for all 5 indications throughout various hematological cancers.To make Libmeldy, the CD34+ cells (cells that can make white blood cells) are extracted within the blood or bone marrow. A gene enabling them to produce ARSA is inserted in to the CD34+ cells employing a styl